OPRK1 and irritable bowel syndrome: Furthermore, despite a distinct safety profile in contrast to typical opioids, opioid-like substances targeting KOR and DOR receptors were also proposed to be potentially useful as clinical analgesics and antidepressants and for the treatment of irritable bowel syndrome (IBS).